nivolumab,denosumab,ipilimumab
daiichi sankyo,amgen,bms
['charli', 'denosumab', 'nivolumab', 'nivo', 'ipilimumab', 'melanoma', 'thank you']
absolute pleasure to present charli: a phase 1b/2 study of nivolumab-denosumab or ipilimumab-nivolumab-denosumab in metastatic melanoma. please stop by poster board 288 in the melanoma session at #asco2023 thank you #melanoma 
Medical Oncologist | Clinician | Researcher | Was @PeterMacCC now @LinearClinical + BCRC-WA & Harry Perkins | Armchair Basketball Critic | Tweets my own opinion